[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":34659000.0,"LeaseCost_1_Q3_USD":534000.0,"InvestmentIncomeAmortizationOfDiscount_3_Q3_USD":75000.0,"HeldToMaturitySecurities_0_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_3_Q3_USD":-443000.0,"DeferredRevenueNoncurrent_0_Q3_USD":648000.0,"ConstructionContractCostProgressPaymentOffset_0_Q3_USD":33200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":141523000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":254200000.0,"AmortizationOfLeaseIncentives_3_Q3_USD":163000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":477000.0,"AmortizationOfFinancingCosts_3_Q3_USD":694000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":28330000.0,"OtherLiabilitiesCurrent_0_Q3_USD":21735000.0,"LeaseCost_3_Q3_USD":1611000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":255411000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":-27783000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":-2398000.0,"TreasuryStockValue_0_Q3_USD":234000.0,"TreasuryStockShares_0_Q3_shares":41309.0,"LongTermNotesPayable_0_Q3_USD":0.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":5893000.0,"LongTermDebtCurrent_0_Q3_USD":14590000.0,"IncreaseDecreaseInInterestPayableNet_3_Q3_USD":238000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":-114000.0,"OtherGeneralAndAdministrativeExpense_3_Q3_USD":25373000.0,"OtherGeneralAndAdministrativeExpense_1_Q3_USD":11584000.0,"NotesPayable_0_Q3_USD":477000.0,"StockOptionPlanExpense_3_Q3_USD":5153000.0,"OtherAssetsCurrent_0_Q3_USD":641000.0,"StockOptionPlanExpense_1_Q3_USD":810000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":18604000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":1797000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_3_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.0034,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":1.8691,"SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_0_Q3_USD":3335275000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1364000.0,"RestrictedStockExpense_3_Q3_USD":41615000.0,"RestrictedStockExpense_1_Q3_USD":27520000.0,"RestrictedCashNoncurrent_0_Q3_USD":1257000.0,"RestrictedCashAndInvestments_0_Q3_USD":1300000.0,"RestrictedCash_0_Q3_USD":1257000.0,"OtherResearchAndDevelopmentExpense_3_Q3_USD":114785000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":10618000.0,"OtherResearchAndDevelopmentExpense_1_Q3_USD":45846000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":8983000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":9806000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1614000.0,"OperatingLeaseLiability_0_Q3_USD":11420000.0,"OperatingLeaseCost_3_Q3_USD":1611000.0,"OperatingLeaseCost_1_Q3_USD":534000.0,"NotesPayableFairValueDisclosure_0_Q3_USD":477000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":30541000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":7184000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":475000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1889000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1911000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1914000.0,"OtherLongTermDebt_0_Q3_USD":30000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0_Q3_shares":147058.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":-1000.0,"NonoperatingIncomeExpense_3_Q3_USD":-4351000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":119176336.0,"Revenues_3_Q3_USD":114000.0,"Revenues_1_Q3_USD":38000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-892379000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":378000.0,"ProfitLoss_3_Q3_USD":-191163000.0,"ProfitLoss_1_Q3_USD":-87163000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":202000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-162481000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":27566000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":276438000.0,"LiabilitiesCurrent_0_Q3_USD":77670000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":273856000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":112380784.0,"Liabilities_0_Q3_USD":103198000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":35296000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.7,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.73,"Depreciation_3_Q3_USD":105000.0,"CommonStockValue_0_Q3_USD":129000.0,"CommonStockSharesOutstanding_0_Q3_shares":128918552.0,"CommonStockSharesIssued_0_Q3_shares":128959861.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":254154000.0,"AssetsCurrent_0_Q3_USD":260335000.0,"Assets_0_Q3_USD":273856000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":11103701.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11103701.0,"AdditionalPaidInCapital_0_Q3_USD":1063142000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":63991000.0,"ProceedsFromWarrantExercises_3_Q3_USD":135000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"NonoperatingIncomeExpense_1_Q3_USD":-1441000.0,"LongTermDebtNoncurrent_0_Q3_USD":15074000.0,"LongTermDebt_0_Q3_USD":29664000.0,"Goodwill_0_Q3_USD":799000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":477000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":170658000.0,"DeferredCompensationLiabilityCurrent_0_Q3_USD":5072000.0,"OtherIncome_3_Q3_USD":687000.0,"OtherIncome_1_Q3_USD":169000.0,"Cash_0_Q3_USD":223613000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":38000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":46768000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensation_1_Q3_USD":28330000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":50464000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OperatingIncomeLoss_3_Q3_USD":-186812000.0,"OperatingIncomeLoss_1_Q3_USD":-85722000.0,"OperatingExpenses_3_Q3_USD":186926000.0,"OperatingExpenses_1_Q3_USD":85760000.0,"NotesPayableCurrent_0_Q3_USD":477000.0,"InterestPaidNet_3_Q3_USD":3447000.0,"InterestExpense_3_Q3_USD":5038000.0,"InterestExpense_1_Q3_USD":1610000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":-1360000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_3_Q3_USD":-105000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":122935000.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":1311000.0,"Ticker":"TGTX","CIK":"1001316","name":"TG THERAPEUTICS, INC.","OfficialName":"TG Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1036853809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]